Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Calcium channel blockers: do they have pleiotropic effects on atherosclerosis?

Journal of Human Hypertension volume 14, pages S96–S99 (2000)Cite this article

Abstract

Since 1980, calcium channel blockers (CCBs) have been used effectively to lower high blood pressure (HBP). Flekestein proposed that CCBs could be used to avoid calcium deposition on the arterial wall, one of the main components of atherosclerosis. This is also called ectopic calcium. This review briefly looks over the current role of CCBs in atherosclerosis and the future based on human trials still in progress.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Departamento de Salud Pública, Universidad Central de Venezuela, UCV, Escuela de Medicina ‘José María Vargas’, Piso 6, San José, Caracas, Venezuela

    IF Soltero Pérez

Authors
  1. IF Soltero Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pérez, I. Calcium channel blockers: do they have pleiotropic effects on atherosclerosis?. J Hum Hypertens 14 (Suppl 1), S96–S99 (2000). https://doi.org/10.1038/sj.jhh.1000994

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1000994

Keywords

Search

Advanced search

Quick links